RD
Robert Driscoll Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
26
Avg Return
Past Year
Past Year
19%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
76.9%
Neutral
19.2%
Negative
3.8%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Underperform
Initiated
| $7 |
49%
downside
| 1 | +7.3% |
0
%
| 26 Feb ‘26 5 days ago |
|
|
|
Outperform
Maintained
| $30 |
199%
upside
| 1 | -17% |
0
%
| 25 Feb ‘26 6 days ago |
|
|
|
Neutral
Maintained
| $11 |
18%
downside
| 2 | – |
–
| 25 Feb ‘26 6 days ago |
|
|
|
Outperform
Maintained
| $52 |
52%
upside
| 1 | +12% |
0
%
| 18 Feb ‘26 13 days ago |
|
|
|
Outperform
Maintained
| $53 |
61%
upside
| 2 | +23% |
0
%
| 13 Feb ‘26 18 days ago |
|
|
|
Outperform
Maintained
| $7 |
724%
upside
| 1 | +29% |
0
%
| 10 Feb ‘26 21 days ago |
|
|
|
Outperform
Maintained
| $19 |
165%
upside
| 3 | +31% |
0
%
| 4 Feb ‘26 27 days ago |
|
|
|
Outperform
Initiated
| $70 |
16%
upside
| 1 | +45% |
0
%
| 11 Dec ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $34 |
116%
upside
| 1 | +26% |
0
%
| 9 Dec ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $38 |
347%
upside
| 2 | +28% |
0
%
| 14 Nov ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $80 |
20%
downside
| 4 | +29% |
0
%
| 6 Nov ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $38 |
363%
upside
| 1 | -58% |
0
%
| 20 Oct ‘25 4 months ago |
|
|
|
Outperform
Initiated
| $27 |
141%
upside
| 1 | -14% |
0
%
| 14 Jul ‘25 7 months ago |
|
|
|
Neutral
Reiterated
| $4 |
68%
upside
| 2 | – |
–
| 15 May ‘25 9 months ago |
|
|
|
Outperform
Maintained
| $6 |
925%
upside
| 2 | -32% |
0
%
| 9 May ‘25 9 months ago |
|
|
|
Outperform
Maintained
| $17 |
5%
downside
| 1 | +154% |
0
%
| 21 Mar ‘25 11 months ago |
|